LGALS4 and colorectal cancer: LGALS4 is significantly downregulated in colorectal cancer, and its overexpression can inhibit cell growth, induce cell cycle arrest, enhance 5-fluorouracil-induced apoptosis, and suppress aerobic glycolysis, suggesting its potential as a novel therapeutic target for colorectal cancer [28].